Literature DB >> 29088311

Assessment of Patient Self-awareness and Related Neural Correlates in Frontotemporal Dementia and Corticobasal Syndrome.

Sarah Levy1, David Gansler1, Edward Huey2, Eric Wassermann3, Jordan Grafman4,5.   

Abstract

OBJECTIVE: We compared two different methods of assessing self-awareness (clinician-rated vs. self- and caregiver report) in participants with neurodegenerative conditions. Additionally, we examined the contribution of memory dysfunction to assessment of self-awareness.
METHOD: Sixty-seven participants with various neurodegenerative disorders participated in this study. Data were collected on brain volume, neurocognitive function, demographic characteristics, and two measures of patient self-awareness, defined as (1) the discrepancy between patient and caregiver ratings of dysexecutive syndrome and (2) clinician-observed rating of patient insight. Penalized regression with best subset variable selection and 10-fold cross-validation was used to evaluate three neurocognitive frameworks: self-regulation, language, and perspective-taking, each predicting the results from the two methods of self-awareness measurement.
RESULTS: The self-regulation framework was more robustly predictive for both the clinician rating and discrepancy method than language or perspective-taking. Frameworks in which the clinician rating was the criterion were more robust than those with the discrepancy method as criterion. When a measure of memory functioning was added to the framework, there was no appreciable improvement in the prediction of self-awareness.
CONCLUSIONS: A self-regulation neurocognitive framework, consisting of regions of interest and neuropsychological test scores, was more effective in understanding patient self-awareness than perspective-taking or language frameworks. Compared to the discrepancy method, a clinician rating of self-awareness was more robustly associated with relevant clinical variables of regional brain volume and neuropsychological performance, suggesting it may be a useful measure to aid clinical diagnosis.

Entities:  

Mesh:

Year:  2018        PMID: 29088311      PMCID: PMC6116784          DOI: 10.1093/arclin/acx105

Source DB:  PubMed          Journal:  Arch Clin Neuropsychol        ISSN: 0887-6177            Impact factor:   2.813


  44 in total

1.  Classification of primary progressive aphasia and its variants.

Authors:  M L Gorno-Tempini; A E Hillis; S Weintraub; A Kertesz; M Mendez; S F Cappa; J M Ogar; J D Rohrer; S Black; B F Boeve; F Manes; N F Dronkers; R Vandenberghe; K Rascovsky; K Patterson; B L Miller; D S Knopman; J R Hodges; M M Mesulam; M Grossman
Journal:  Neurology       Date:  2011-02-16       Impact factor: 9.910

Review 2.  Self-awareness and the medial temporal lobe in neurodegenerative diseases.

Authors:  Chantal Chavoix; Ricardo Insausti
Journal:  Neurosci Biobehav Rev       Date:  2017-04-19       Impact factor: 8.989

3.  Normalization of cerebral volumes by use of intracranial volume: implications for longitudinal quantitative MR imaging.

Authors:  J L Whitwell; W R Crum; H C Watt; N C Fox
Journal:  AJNR Am J Neuroradiol       Date:  2001-09       Impact factor: 3.825

4.  Significant grey matter changes in a region of the orbitofrontal cortex in healthy participants predicts emotional dysregulation.

Authors:  Predrag Petrovic; Carl Johan Ekman; Johanna Klahr; Lars Tigerström; Göran Rydén; Anette G M Johansson; Carl Sellgren; Armita Golkar; Andreas Olsson; Arne Öhman; Martin Ingvar; Mikael Landén
Journal:  Soc Cogn Affect Neurosci       Date:  2015-06-15       Impact factor: 3.436

5.  Decoding the Charitable Brain: Empathy, Perspective Taking, and Attention Shifts Differentially Predict Altruistic Giving.

Authors:  Anita Tusche; Anne Böckler; Philipp Kanske; Fynn-Mathis Trautwein; Tania Singer
Journal:  J Neurosci       Date:  2016-04-27       Impact factor: 6.167

6.  Characteristics of impaired awareness after traumatic brain injury.

Authors:  M Sherer; C Boake; E Levin; B V Silver; G Ringholz; W M High
Journal:  J Int Neuropsychol Soc       Date:  1998-07       Impact factor: 2.892

7.  The neurobehavioural rating scale: assessment of the behavioural sequelae of head injury by the clinician.

Authors:  H S Levin; W M High; K E Goethe; R A Sisson; J E Overall; H M Rhoades; H M Eisenberg; Z Kalisky; H E Gary
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-02       Impact factor: 10.154

8.  "Keep calm and carry on": structural correlates of expressive suppression of emotions.

Authors:  Simone Kühn; Jürgen Gallinat; Marcel Brass
Journal:  PLoS One       Date:  2011-01-26       Impact factor: 3.240

9.  Neural substrates of socioemotional self-awareness in neurodegenerative disease.

Authors:  Marc Sollberger; Howard J Rosen; Tal Shany-Ur; Jerin Ullah; Christine M Stanley; Victor Laluz; Michael W Weiner; Stephen M Wilson; Bruce L Miller; Katherine P Rankin
Journal:  Brain Behav       Date:  2014-01-13       Impact factor: 2.708

10.  Impaired self-awareness after traumatic brain injury: inter-rater reliability and factor structure of the Dysexecutive Questionnaire (DEX) in patients, significant others and clinicians.

Authors:  Brian E McGuire; Todd G Morrison; Lynne A Barker; Nicholas Morton; Judith McBrinn; Sheena Caldwell; Colin F Wilson; John McCann; Simone Carton; Mark Delargy; Jane Walsh
Journal:  Front Behav Neurosci       Date:  2014-10-10       Impact factor: 3.558

View more
  2 in total

1.  Anosognosia in Dementia: Evaluation of Perfusion Correlates Using 99mTc-HMPAO SPECT and Automated Brodmann Areas Analysis.

Authors:  Varvara Valotassiou; Nikolaos Sifakis; Chara Tzavara; Evi Lykou; Niki Tsinia; Vasiliki Kamtsadeli; Dimitra Sali; George Angelidis; Dimitrios Psimadas; Eudoxia Theodorou; Ioannis Tsougos; Sokratis G Papageorgiou; Panagiotis Georgoulias; John Papatriantafyllou
Journal:  Diagnostics (Basel)       Date:  2022-05-04

2.  Neural correlates of altered insight in frontotemporal dementia: a systematic review.

Authors:  Carlos Muñoz-Neira; Andrea Tedde; Elizabeth Coulthard; N Jade Thai; Catherine Pennington
Journal:  Neuroimage Clin       Date:  2019-11-05       Impact factor: 4.881

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.